Search results for "Human gut"

showing 10 items of 11 documents

Relevance of secretor status genotype and microbiota composition in susceptibility to rotavirus and norovirus infections in humans

2017

Host genetic factors, such as histo-blood group antigens (HBGAs), are associated with susceptibility to norovirus (NoV) and rotavirus (RV) infections. Recent advances point to the gut microbiome as a key player necessary for a viral pathogen to cause infection. In vitro NoV attachment to host cells and resulting infections have been linked to interactions with certain bacterial types in the gut microbiota. We investigated the relationship between host genotype, gut microbiota, and viral infections. Saliva and fecal samples from 35 adult volunteers were analysed for secretor status genotype, the gut microbiota composition by 16S rRNA gene sequencing, and salivary IgA titers to NoV and RV. Hi…

0301 basic medicineAdultMaleSalivaGenotype030106 microbiologyResistanceMicrobiologiaGut floraHuman gut microbiomemedicine.disease_causeArticleRotavirus InfectionsMicrobiologyAssociation03 medical and health sciencesFecesfluids and secretionsBlood group antigensFut2 geneRotavirusGenotypemedicineHumansGenetic Predisposition to DiseaseDiseaseMicrobiomePolymorphismSalivaPathogenEcosystemCaliciviridae InfectionsMultidisciplinaryEnteric bacteriabiologyRuminococcusMiddle Agedbiology.organism_classificationFucosyltransferasesVirusGastrointestinal MicrobiomeGastroenteritis030104 developmental biologyImmunologyNorovirusFemale
researchProduct

Potential benefits of high-added-value compounds from aquaculture and fish side streams on human gut microbiota

2021

Background: Human gut microbiota dysbiosis has been linked to a higher risk of non-communicable diseases (NCDs) such us inflammatory disorders, allergy and obesity. Specific dietary strategies, including the use of specific food supplements targeted to microbiota modulation, have been suggested to be especially relevant in reducing the risk of NCDs. In this regard, marine environment is considered as a pivotal source of nutrients and bioactive compounds such as polyunsaturated fatty acids, polysaccharides and active peptides. These compounds, including algae- (alginate, fucoidan) and animal-derived polysaccharides (chitin, chitosan), among others, have been widely studied. The use of these …

0301 basic medicineAquatic lifeGut microbiotaGut floraFats03 medical and health sciencesHuman healthHuman gutAquaculturePolysaccharidesmedicineFood science2. Zero hungerchemistry.chemical_classification030109 nutrition & dieteticsbiologybusiness.industryProteinmedicine.diseasebiology.organism_classification3. Good healthSide streams030104 developmental biologychemistry13. Climate actionFish <Actinopterygii>businessDysbiosisFood ScienceBiotechnologyPolyunsaturated fatty acid
researchProduct

Active and Secretory IgA-Coated Bacterial Fractions Elucidate Dysbiosis in Clostridium difficile Infection

2016

C. difficile is a major enteric pathogen with worldwide distribution. Its expansion is associated with broad-spectrum antibiotics which disturb the normal gut microbiome. In this study, the DNA sequencing of highly active bacteria and bacteria opsonized by intestinal secretory immunoglobulin A (SIgA) separated from the whole bacterial community by FACS elucidated how the gut dysbiosis promotes C. difficile infection (CDI). Bacterial groups with inhibitory effects on C. difficile growth, such as Lactobacillales, were mostly inactive in the CDI patients. C. difficile was typical for the bacterial fraction opsonized by SIgA in patients with CDI, while Fusobacterium was characteristic for the S…

0301 basic medicineClostridium Cluster IVmedicine.drug_class030106 microbiologyAntibioticslcsh:QR1-502Microbiologylcsh:MicrobiologyantibioticsMicrobiologyHost-Microbe Biology03 medical and health sciencesClostridium difficile infectionmedicineMicrobiomeMolecular Biology16S rRNA gene sequencinghuman gut microbiomebiologyLactobacillalesdysbiosisClostridium difficilebiology.organism_classificationmedicine.diseaseQR1-502030104 developmental biologyBayesian networksFusobacteriumImmunologysecretory immunoglobulin ADysbiosisBacteriafluorescence-activated cell sortingResearch ArticlemSphere
researchProduct

Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances

2016

The human microbiome is overly exposed to antibiotics, due, not only to their medical use, but also to their utilization in farm animals and crops. Microbiome composition can be rapidly altered by exposure to antibiotics, with potential immediate effects on health, for instance through the selection of resistant opportunistic pathogens that can cause acute disease. Microbiome alterations induced by antibiotics can also indirectly affect health in the long-term. The mutualistic microbes in the human body interact with many physiological processes, and participate in the regulation of immune and metabolic homeostasis. Therefore, antibiotic exposure can alter many basic physiological equilibri…

0301 basic medicineMicrobiology (medical)resistance reservoirmedicine.drug_classAntibioticslcsh:QR1-502atopyReviewGut floraMicrobiologylcsh:MicrobiologyantibioticsMicrobiology03 medical and health sciencesAntibiotic resistanceImmune systemImmunityhuman gut microbiotamedicineMicrobiomebiologyautoimmunityHuman microbiomedysbiosisbiology.organism_classificationmedicine.disease030104 developmental biologyinflammationImmunologyDysbiosisimmunotoleranceFrontiers in Microbiology
researchProduct

An extended reconstruction of human gut microbiota metabolism for personalized nutrition

2020

ABSTRACTUnderstanding how diet and gut microbiota interact in the context of human health is a key question in personalized nutrition. Genome-scale metabolic networks and constraint-based modeling approaches are promising to systematically address this complex question. However, when applied to nutritional questions, a major issue in existing reconstructions is the lack of information about degradation pathways of relevant nutrients in the diet that are metabolized by the gut microbiota. Here, we present AGREDA, an extended reconstruction of the human gut microbiota metabolism for personalized nutrition. AGREDA includes the degradation pathways of 231 nutrients present in the human diet and…

Human healthHuman gutPersonalized nutritionContext (language use)Computational biologyBiologyGut florabiology.organism_classificationdigestive system
researchProduct

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach

2014

It is known that the gastrointestinal tract (GIT) microbiota responds to different antibiotics in different ways and that while some antibiotics do not induce disturbances of the community, others drastically influence the richness, diversity, and prevalence of bacterial taxa. However, the metabolic consequences thereof, independent of the degree of the community shifts, are not clearly understood. In a recent article, we used an integrative OMICS approach to provide new insights into the metabolic shifts caused by antibiotic disturbance. The study presented here further suggests that specific bacterial lineage blooms occurring at defined stages of antibiotic intervention are mostly associa…

MaleAnabolismAntibioticsGene ExpressionGut floraGastrointestinal FunctionBioinformaticsprokaryotesFecesRNA Ribosomal 16SSystems and Synthetic Biologyhuman fecal microbiota1506MetaproteomicGut Microbiotadatabase2. Zero hungerlong-term impactsGastrointestinal tract0303 health sciencesSysteem en Synthetische Biologiehuman intestinal microbiotabiologyMicrobiotaGastroenterologyBiodiversity3. Good healthAnti-Bacterial AgentsBacterial Typing TechniquesArticle AddendumRNA BacterialInfectious DiseasesMetabolomecommunitymetaproteomicsHuman gut microbiotaMicrobiology (medical)DNA BacterialDisturbance (geology)medicine.drug_classperturbationMetabolomicbeta-LactamsMicrobiologyMicrobiologyresistance03 medical and health sciencesMetagenomicAntibiotic therapyMetabolomemedicineHumans030304 developmental biologyAgedVLAGBacteria030306 microbiologyGene Expression ProfilingColonic MicrofloraAkkermansiaAntibiotic therapybiology.organism_classificationGastrointestinal TractEnterococcusGene Expression RegulationMetaproteomicsMetatranscriptomicGastrointestinal functionmetabolismMeta-Analysis
researchProduct

Direct sequencing of human gut virome fractions obtained by flow cytometry

2015

The sequence assembly of the human gut virome encounters several difficulties. A high proportion of human and bacterial matches is detected in purified viral samples. Viral DNA extraction results in a low DNA concentration, which does not reach the minimal limit required for sequencing library preparation. Therefore, the viromes are usually enriched by whole genome amplification, which is, however, prone to the development of chimeras and amplification bias. In addition, as there is a very wide diversity of gut viral species, very extensive sequencing efforts must be made for the assembling of whole viral genomes. We present an approach to improve human gut virome assembly by employing a mo…

Microbiology (medical)Whole Genome AmplificationGeneticsbacteriophagesmedicine.diagnostic_testContigwhole genome amplificationhuman gut viromelcsh:QR1-502Sequence assemblyfluorescent activated cell sortingBiologyde novo assemblyMicrobiologylcsh:MicrobiologyFlow cytometryOpen reading framechemistry.chemical_compoundchemistrymedicineHuman viromeORFSDNAOriginal ResearchFrontiers in Microbiology
researchProduct

Early Development of the Gut Microbiota and Immune Health

2014

In recent years, the increase in human microbiome research brought about by the rapidly evolving “omic” technologies has established that the balance among the microbial groups present in the human gut, and their multipronged interactions with the host, are crucial for health. On the other hand, epidemiological and experimental support has also grown for the ‘early programming hypothesis’, according to which factors that act in utero and early in life program the risks for adverse health outcomes later on. The microbiota of the gut develops during infancy, in close interaction with immune development, and with extensive variability across individuals. It follows that the specific process of…

Microbiology (medical)atopylcsh:MedicineReviewDiseaseinfant gutBiologyGut floraHealth outcomesantibioticsImmune systemHuman gutImmunology and Allergyearly programmingmicrobe-host interactionsMolecular BiologyGut colonizationIntrauterine transmissionnecrotizing enterocolitisgut microbiotaGeneral Immunology and Microbiologylcsh:RHuman microbiomehuman microbiomebiology.organism_classificationintrauterine transmissionInfectious DiseasesImmunologyimmune diseasePathogens
researchProduct

Adaptation of the Human Gut Microbiota Metabolic Network During the First Year After Birth

2019

Predicting the metabolic behavior of the human gut microbiota in different contexts is one of the most promising areas of constraint-based modeling. Recently, we presented a supra-organismal approach to build context-specific metabolic networks of bacterial communities using functional and taxonomic assignments of meta-omics data. In this work, this algorithm is applied to elucidate the metabolic changes induced over the first year after birth in the gut microbiota of a cohort of Spanish infants. We used metagenomics data of fecal samples and nutritional data of 13 infants at five time points. The resulting networks for each time point were analyzed, finding significant alterations once sol…

Microbiology (medical)lcsh:QR1-502Metabolic networkComputational biologyBiologyGut floradigestive systemMicrobiologylcsh:Microbiology03 medical and health sciencesMetabolomicsHuman gutpersonalized nutritionFecesOriginal Research030304 developmental biologyhuman gut microbiomemetagenomics0303 health sciences030306 microbiologyExperimental validationbiology.organism_classificationmetabolomicsMetagenomicsmetabolic networksAdaptation
researchProduct

Cross-regional view of functional and taxonomic microbiota composition in obesity and post-obesity treatment shows country specific microbial contrib…

2019

This work was supported by CONICYT-Chile through the FONDECYT [n° 3160525] (DM) and by Universidad San Sebastián, and by grants to AM from the Spanish Ministry of Economy and Competitiveness (projects SAF2012-31187, SAF2013-49788-EXP, SAF2015-65878-R), Carlos III Health Institute (Projects PIE14/00045 and AC15/00022), Generalitat Valenciana (Project PrometeoII/2014/065 and Prometeo/2018/A/133), Asociación Española Contra el Cancer (Project AECC 2017-1485) and co-financed by the European Regional Development Fund (ERDF).

Microbiology (medical)obesitybariatric surgerylcsh:QR1-502Context (language use)Gut floraMicrobiologydigestive systemlcsh:MicrobiologyFunctional redundancy03 medical and health sciencesMetagenomicWeight losshuman gut microbiotamedicineObesitymetagenomicOriginal Research030304 developmental biologyGeneticsBariatric surgery0303 health sciencesbiology030306 microbiologyMicrobiotaFunctional redundancyfunctional convergencebiology.organism_classificationmedicine.diseaseObesityfunctional redundancyMetagenomicsObesitatmedicine.symptomDysbiosisAkkermansia muciniphilaFunctional convergenceHuman gut microbiota
researchProduct